AgingResearch.NewsJoin free

E-ev-p@hpcep

Intervention

1 paper studies it3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: China Postdoctoral Science Foundation and 2 more
  • Animals1

Outcomes

3

Cellular senescence

downin cells1

1 study

  1. E-ev-p@hpcep inhibits cellular senescence in cells.

    “orchestrating a transformation in the inflammatory-senescent milieu following injury”

    Cellsfollowing peripheral nerve injury

    Mitigating Critical Peripheral Nerve Deficit Therapy with Reactive Oxygen Species/Ca²⁺-Responsive Dynamic Hydrogel-Mediated mRNA Delivery

    ACS nanoJun 18, 2024

More on Cellular senescence

Mitophagy

upin cells1

1 study

  1. E-ev-p@hpcep activates mitophagy in cells.

    “through the stimulation of autophagy within the mitochondria of the injured cells and the maintenance of mitochondrial mass equilibrium”

    Cellsin injured cells

    Mitigating Critical Peripheral Nerve Deficit Therapy with Reactive Oxygen Species/Ca²⁺-Responsive Dynamic Hydrogel-Mediated mRNA Delivery

    ACS nanoJun 18, 2024

More on Mitophagy

Wallerian degeneration

downin cells1

1 study

  1. E-ev-p@hpcep inhibits Wallerian degeneration in cells.

    “thereby stymying the progression of WD in peripheral nerve fibers through the stimulation of autophagy within the mitochondria of the injured cells”

    Cellsin peripheral nerve fibers following injury

    Mitigating Critical Peripheral Nerve Deficit Therapy with Reactive Oxygen Species/Ca²⁺-Responsive Dynamic Hydrogel-Mediated mRNA Delivery

    ACS nanoJun 18, 2024

More on Wallerian degeneration

Latest

Related